Literature DB >> 16985604

The role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction.

John Gore, Jacob Rajfer.   

Abstract

As oral phosphodiesterase-5 inhibitor therapy has become the first-line treatment of erectile dysfunction (ED), common approaches in the evaluation of ED have been largely abandoned. Not only is routine hormone analysis no longer widely recommended, but most specialists perform serum testosterone level testing only in the most complex cases of ED. This article explores the rationale for including serum testosterone analysis as part of the initial screening of patients with ED. The use of routine serum testosterone testing is advocated for its efficacy in the diagnosis and treatment of hypogonadism and pituitary disorders associated with ED.

Entities:  

Year:  2004        PMID: 16985604      PMCID: PMC1472839     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  18 in total

1.  Is routine endocrine testing of impotent men necessary?

Authors:  A R Johnson; J P Jarow
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

2.  Effects of castration and androgen replacement on erectile function in a rabbit model.

Authors:  A M Traish; K Park; V Dhir; N N Kim; R B Moreland; I Goldstein
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

3.  Testosterone supplementation for erectile dysfunction: results of a meta-analysis.

Authors:  P Jain; A W Rademaker; K T McVary
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

Review 4.  Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.

Authors:  J Buvat; A Lemaire
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

5.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

Authors:  Henry A Feldman; Christopher Longcope; Carol A Derby; Catherine B Johannes; Andre B Araujo; Andrea D Coviello; William J Bremner; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

6.  Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy?

Authors:  Carolyn M Earle; Bronwyn G A Stuckey
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

7.  Laboratory evaluations of erectile dysfunction: an evidence based approach.

Authors:  Joshua Bodie; Jean Lewis; Doug Schow; Manoj Monga
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

8.  Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone.

Authors:  S Y Kalinchenko; G I Kozlov; N P Gontcharov; G V Katsiya
Journal:  Aging Male       Date:  2003-06       Impact factor: 5.892

9.  Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.

Authors:  Annamaria Morelli; Sandra Filippi; Rosa Mancina; Michaela Luconi; Linda Vignozzi; Mirca Marini; Claudio Orlando; Gabriella Barbara Vannelli; Antonio Aversa; Alessandro Natali; Gianni Forti; Mauro Giorgi; Emmanuele A Jannini; Fabrizio Ledda; Mario Maggi
Journal:  Endocrinology       Date:  2004-02-05       Impact factor: 4.736

10.  Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction.

Authors:  Antonio Aversa; Andrea M Isidori; Giovanni Spera; Andrea Lenzi; Andrea Fabbri
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

View more
  2 in total

1.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

Review 2.  Testosterone for the aging male; current evidence and recommended practice.

Authors:  Roger D Stanworth; T Hugh Jones
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.